article thumbnail

Off-Label Semaglutide Linked to Deaths, Hospitalizations Calling for Compounding Regulation

Pharmacy Times

Off-label semaglutide has been linked to serious adverse effects, calling for increased regulation around compounding.

article thumbnail

STAT+: New Wegovy analysis could boost Novo Nordisk’s bid to expand drug’s label in heart failure

STAT

Novo Nordisk’s obesity drug Wegovy cut the risk of severe complications in patients with a common form of heart failure, according to a new analysis that could boost the company’s efforts to expand the label for the blockbuster treatment. of those who received placebo. of those who received placebo.

Labelling 131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How and why pharmacists should get involved in clinical research

Hospital Pharmacy Europe

For pharmacists with the will, time and support to get involved in clinical research, the benefits are many not only for them, but also for their patients, teams and hospitals. With a workforce under pressure, getting involved in clinical trials and pilot research projects might be the last thing on hospital pharmacists minds.

article thumbnail

FDA Approves Expanded Label for Dapagliflozin to Reduce Risk of Cardiovascular Death, Hospitalization from Heart Failure

Pharmacy Times

Dapagliflozin was established as the first SGLT2 inhibitor that demonstrated a mortality benefit for cardiovascular death from heart failure.

Labelling 123
article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

Hospital clinicians should never have to decide whether our +RFID products are compatible; medications should work effortlessly in whatever system a hospital wants to purchase. RFID is an important facet of smart labelling and its evolution, but not the only one. That is where GS1 standards come in,” says Volpe.

Labelling 105
article thumbnail

The hospital pharmacy landscape in 2024

Hospital Pharmacy Europe

Tiene Bauters, PharmD PhD, Pharmacy Department , Ghent University Hospital in Belgium, offers her take on what’s hot on the horizon for hospital pharmacy in 2024. These will undoubtedly present great opportunities for hospital pharmacists and their teams.

Hospitals 111
article thumbnail

STAT+: Novo Nordisk pulls filings for Wegovy in heart failure as it waits for cardiovascular outcomes data

STAT

The company plans to reapply to expand Wegovy’s label early next year when it has more data on complications such as hospitalizations and cardiovascular-related deaths, Martin Lange, Novo’s head of development, said Wednesday on an earnings call. and Europe. Continue to STAT+ to read the full story…

Hospitals 126